Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study
Open Access
- 15 February 2021
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (6) , 1397-1402
Abstract
Objective: To evaluate the efficacy and safety of intravenous immunoglobulin G (IVIG) in infants with ABO hemolytic disease of the newborn (HDN). Methods: Infants with moderate-to-severe ABO HDN during early neonatal period (P = 0.20, 0.27, 0.65, 0.47, 0.78, respectively). Conclusion: It seems unnecessary to expose neonates to IVIG in moderate-to-severe ABO HDN when the available data show no appreciable benefits.Keywords
This publication has 21 references indexed in Scilit:
- Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in TurkeyThe Journal of Maternal-Fetal & Neonatal Medicine, 2014
- Efficacité et tolérance des immunoglobulines polyvalentes dans l’hyperbilirubinémie néonatale par incompatibilité ABO. Méta-analyseArchives de Pédiatrie, 2014
- Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2014
- Intravenous Immunoglobulin and Necrotizing Enterocolitis in Newborns With Hemolytic DiseasePediatrics, 2010
- A Decline in the Frequency of Neonatal Exchange Transfusions and Its Effect on Exchange-Related Morbidity and MortalityPediatrics, 2007
- Haemolytic disease of the newborn: Table 1Archives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newbornThe Journal of Maternal-Fetal & Neonatal Medicine, 2004
- Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of GestationPediatrics, 2004
- Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis?European Journal of Pediatrics, 1991
- Substitutive-Inhibitory Gamma Globulin Therapy as Prevention of Stillbirth in Rh–IncompatibilityActa Haematologica, 1965